Ads
related to: Abbvie- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Read AbbVie Stories
Read Stories About Our Science,
People, and More Today.
- Investor Resources
Find Financial Reports, Stock Info
And More Resources For Investors.
- Supporting Our Workforce
Embracing Equality & Diversity
Makes Us More Innovative.
- AbbVie News Center
Search results
California State Teachers Retirement System Acquires 42,587 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoCalifornia State Teachers Retirement System raised its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.5% in the 4th quarter, according to the company in ...
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks via Yahoo Finance· 1 day agoThe Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
AbbVie (ABBV) Soars 3.2%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 6 days agoAbbVie (ABBV) saw its shares surge in the last session with trading volume being higher than...
AbbVie's Immunogen Acquired Elahere Meets Primary Goal In Mid-Stage Study In Heavily Pretreated...
Benzinga· 2 days agoOn Thursday, AbbVie Inc ABBV released topline results from the Phase 2 PICCOLO trial evaluating...
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena via Yahoo Finance· 2 days agoAbbVie has treated the first subject in the Phase III CERVINO clinical trial of its investigational...
AbbVie Launches First-of-its-Kind Contest to Empower People Living with Migraine in their Careers
The Parsons Sun· 2 days agoWith more than 113 million workdays lost in the U.S. each year to the disease and its symptoms, migraine can have a major impact in the workplace.1 Twenty contest entrants will win up to $2,500 ...
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Finance· 5 days agoThe latest trading session saw AbbVie (ABBV) ending at $160.19, denoting a -0.65% adjustment from...
AbbVie (ABBV) Could Be a Great Choice
Zacks via Yahoo Finance· 5 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?...
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 5 days agoAbbVie has announced positive data for its antibody-drug conjugate (ADC) therapies, Teliso-V,...
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
Zacks· 6 days agoFree Report) ending at $160.19, denoting a -0.65% adjustment from its last day's close. This change lagged the S&P 500's 0.11% gain on the day. In that same time, the Medical sector gained 2.86% ...
Ad
related to: Abbvie